Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Conditions

• Cervical Cancer
• Vulvar Cancer
• Vaginal Cancer
• Genital Warts
• Human Papillomavirus Infection

Interventions

• BIOLOGICAL: Comparator: V505 formulation 1
• DRUG: Comparator: V505 formulation 2
• DRUG: Comparator: V505 formulation 2
• BIOLOGICAL: Comparator: V505 formulation 3
• BIOLOGICAL: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant
• BIOLOGICAL: Comparator: Placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC